Principal Financial Group Inc. Has $31.37 Million Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Principal Financial Group Inc. raised its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 2.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 4,006,344 shares of the company's stock after acquiring an additional 110,457 shares during the period. Principal Financial Group Inc. owned approximately 1.06% of LifeStance Health Group worth $31,370,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the stock. Sunbelt Securities Inc. bought a new stake in LifeStance Health Group in the third quarter valued at about $34,000. DekaBank Deutsche Girozentrale acquired a new stake in shares of LifeStance Health Group in the 3rd quarter valued at approximately $34,000. Stratos Wealth Partners LTD. acquired a new stake in shares of LifeStance Health Group in the 4th quarter valued at approximately $93,000. WINTON GROUP Ltd bought a new position in LifeStance Health Group during the 3rd quarter worth approximately $134,000. Finally, Jump Financial LLC acquired a new position in LifeStance Health Group during the third quarter valued at approximately $157,000. Institutional investors and hedge funds own 85.50% of the company's stock.

LifeStance Health Group Stock Up 0.3 %

LFST stock traded up $0.02 during trading hours on Friday, reaching $7.39. 645,928 shares of the stock were exchanged, compared to its average volume of 1,131,638. The firm's 50-day moving average is $6.37 and its 200-day moving average is $6.64. LifeStance Health Group, Inc. has a 12 month low of $4.74 and a 12 month high of $9.59. The company has a market cap of $2.83 billion, a price-to-earnings ratio of -15.40 and a beta of 1.29. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.18 and a quick ratio of 1.18.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last posted its quarterly earnings data on Thursday, May 9th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.09) by $0.03. The business had revenue of $300.44 million during the quarter, compared to the consensus estimate of $299.02 million. LifeStance Health Group had a negative return on equity of 11.92% and a negative net margin of 15.69%. LifeStance Health Group's quarterly revenue was up 18.9% on a year-over-year basis. During the same period last year, the company earned ($0.09) earnings per share. On average, equities research analysts expect that LifeStance Health Group, Inc. will post -0.27 earnings per share for the current year.

Insider Transactions at LifeStance Health Group

In related news, insider Danish J. Qureshi sold 12,965 shares of the firm's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $5.93, for a total value of $76,882.45. Following the completion of the transaction, the insider now owns 4,911,050 shares of the company's stock, valued at $29,122,526.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, insider Paula Cipollone sold 48,278 shares of the company's stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $7.22, for a total transaction of $348,567.16. Following the sale, the insider now owns 239,915 shares in the company, valued at approximately $1,732,186.30. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Danish J. Qureshi sold 12,965 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $5.93, for a total value of $76,882.45. Following the completion of the sale, the insider now directly owns 4,911,050 shares of the company's stock, valued at approximately $29,122,526.50. The disclosure for this sale can be found here. Insiders have sold a total of 295,741 shares of company stock valued at $2,149,435 over the last 90 days. 6.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on LFST. Jefferies Financial Group increased their target price on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a "buy" rating in a report on Wednesday, March 6th. Barclays boosted their target price on LifeStance Health Group from $7.00 to $8.00 and gave the company an "underweight" rating in a research note on Thursday, February 29th. The Goldman Sachs Group raised their price target on LifeStance Health Group from $8.00 to $9.00 and gave the stock a "neutral" rating in a research report on Monday, March 4th. Finally, Morgan Stanley reiterated an "overweight" rating and issued a $10.00 price objective on shares of LifeStance Health Group in a research report on Monday, April 22nd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, LifeStance Health Group currently has a consensus rating of "Hold" and a consensus price target of $8.80.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.